Astellas Pharma Inc. Stock Deutsche Boerse AG
Stocks
YPHA
US04623U1025
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
02:06:15 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 12.70 EUR | +2.42% |
|
+4.96% | +14.41% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,240B 27.17B 23.68B 22.4B 20.35B 38.01B 2,607B 38.24B 265B 103B 1,326B 102B 99.84B | P/E 2027 * |
11.3x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4,181B 26.79B 23.35B 22.09B 20.07B 37.48B 2,571B 37.7B 261B 102B 1,307B 101B 98.45B | EV / Sales 2027 * |
1.79x | EV / Sales 2028 * | 1.72x |
| Free-Float |
98.92% | Yield 2027 * |
3.39% | Yield 2028 * | 3.51% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| ALPMY | Delayed | |
Deutsche Boerse AG
| YPHA | Delayed |
Last Transcript: Astellas Pharma Inc.
| 1 day | +2.42% | ||
| 1 week | +4.96% | ||
| Current month | +4.10% | ||
| 1 month | +3.25% | ||
| 3 months | +14.41% | ||
| 6 months | +0.79% | ||
| Current year | +14.41% |
| 1 week | 12.1 |  | 12.7 |
| 1 month | 11.9 | | 12.7 |
| Current year | 10.8 | | 14.1 |
| 1 year | 8.6 | | 14.1 |
| 3 years | 7.5 | | 14.1 |
| 5 years | 7.5 | | 15.6 |
| 10 years | 7.5 | | 16.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 64 | 2019-05-31 |
| Director/Board Member | 59 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | +4.96% | - | - | 26.75B | |
| +1.28% | +2.51% | +50.70% | +100.19% | 1,014B | |
| +1.10% | +1.18% | +53.13% | +67.37% | 644B | |
| +0.58% | +5.22% | +22.08% | +73.56% | 464B | |
| -0.36% | +3.88% | +39.78% | +38.21% | 354B | |
| +1.52% | +3.90% | +19.76% | +25.75% | 265B | |
| +2.41% | +6.68% | +9.54% | +13.60% | 253B | |
| +0.91% | -2.94% | +39.07% | +45.67% | 203B | |
| +2.48% | -3.31% | -22.21% | -58.09% | 186B | |
| +2.17% | +3.60% | +36.11% | +99.41% | 183B | |
| Average | +1.23% | +0.96% | +27.55% | +45.07% | 396.31B | |
| Weighted average by Cap. | +0.68% | +1.41% | +35.90% | +61.57% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,338B 14.98B 13.06B 12.35B 11.22B 20.96B 1,438B 21.08B 146B 56.81B 731B 56.29B 55.05B | 2,180B 13.97B 12.18B 11.52B 10.46B 19.54B 1,340B 19.66B 136B 52.97B 682B 52.48B 51.33B |
| Net income | 361B 2.31B 2.02B 1.91B 1.73B 3.24B 222B 3.26B 22.56B 8.77B 113B 8.69B 8.5B | 340B 2.18B 1.9B 1.79B 1.63B 3.04B 209B 3.06B 21.22B 8.25B 106B 8.18B 8B |
| Net Debt | -59.18B -379M -331M -313M -284M -530M -36.39B -534M -3.7B -1.44B -18.5B -1.42B -1.39B | -481B -3.08B -2.68B -2.54B -2.31B -4.31B -296B -4.33B -30.03B -11.68B -150B -11.57B -11.32B |
| Date | Price | Change |
|---|---|---|
| 26-09-17 | €12.70 | +2.42% |
| 26-09-16 | €12.40 | -1.59% |
| 26-09-15 | €12.60 | +2.44% |
| 26-09-14 | €12.30 | +1.65% |
| 26-09-11 | €12.10 | +1.68% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- YPHA Stock
Select your edition
All financial news and data tailored to specific country editions
